Market Tracker

04/23 1:33pm ET
40.16
BATS BZX Real-Time Price
As of 1:28pm ET
 +0.20 / +0.50%
Today’s Change
38.14
Today|||52-Week Range
50.65
-6.60%
Year-to-Date
Shire (SHPG) Turns Down Takeda's Third Buyout Proposition
Apr 20 / Zacks.com - Paid Partner Content
Top Analyst Reports for AbbVie, Berkshire & PepsiCo
Apr 17 / Zacks.com - Paid Partner Content
Sanofi to Divest European Generic Unit, Streamline Business
Apr 19 / Zacks.com - Paid Partner Content
Alexion (ALXN) to Acquire Wilson Therapeutics for $855M
Apr 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close39.96
Today’s open40.33
Day’s range40.09 - 40.33
Volume57,118
Average volume (3 months)1,700,759
Market cap$100.9B
Data as of 1:28pm ET, 04/23/2018

Growth & Valuation

Earnings growth (last year)-15.68%
Earnings growth (this year)+1.33%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+5.92%
P/E ratio22.0
Price/Sales2.73
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie+0.70+0.75%
CELGCelgene+0.29+0.33%
BMYBristol-Myers Squibb-0.31-0.61%
GSKGlaxoSmithKline+0.25+0.63%
Data as of 1:33pm ET, 04/23/2018

Financials

Next reporting dateApril 27, 2018
EPS forecast (this quarter)$0.84
Annual revenue (last year)$39.5B
Annual profit (last year)$4.3B
Net profit margin10.81%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Olivier Brandicourt
Chief Financial Officer &
Executive VP-Finance
Jérôme Contamine
Corporate headquarters
Paris, Ile-de-france

Forecasts